Multiple epiphyseal dysplasia (MED), also known as dysplasia epiphysealis multiplex or Fairbank disease, refers to a group of skeletal dysplasias characterized by disorganized enchondral epiphyseal ossification in the long bones.
On this page:
Epidemiology
The estimated prevalence of MED ranges from 1 in 20.000 to 1 in 10.000 1,2.
Clinical presentation
Although many forms of MED have different genetic and phenotypic expressions, most share the common presentation of joint pain, especially in the hips and knees. Mild to moderate short stature is common, but not mandatory. Muscular hypotonia indicates MED caused by the COMP (cartilage oligomeric matrix protein) gene mutation. Club feet are often associated with the recessive form of the disease (rMED) and are present in nearly a third of individuals with rMED 1.
Pathology
Currently (c. 2024) there are six genetic mutations related to MED 2:
COMP: autosomal dominant, ~50% of the cases
DTDST (SCL26A2): autosomal recessive, ~25% of the cases
MATN3: autosomal dominant
COL9A2: autosomal dominant
COL9A3: autosomal dominant
COL9A1: autosomal dominant, very rare
Radiographic features
Given the genetic etiology of the disease, the findings are symmetric and include 1,3:
delayed appearance of epiphyseal ossification centers
irregular, fragmented flattened epiphyses
Widened joint spaces4
delayed carpal ossification (COMP-MED)
coxa vara (COMP-MED) or coxa valga (rMED)
double-layered patella (often considered pathognomonic for MED, especially rMED)
‘snowcap’ appearance of the metacarpal epiphyses (rMED)
brachydactyly (rMED)
Treatment and prognosis
The goal of treatment is to delay the development of early osteoarthritis. Adequate weight control and avoiding high-impact exercises are common measures to reduce stress on weight-bearing joints, which are the most affected ones. Surgical intervention may be considered in case of failure of non-operative management and progressive deformities. In early adulthood, total joint replacements, especially of the knees and hips, are usually indicated due to advanced osteoarthritis 1-3.